GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $594,000 | +1.2% | 18,600 | +9.7% | 0.38% | +20.6% |
| Q1 2022 | $587,000 | +35.6% | 16,950 | +14.5% | 0.32% | +29.1% |
| Q4 2021 | $433,000 | +15.5% | 14,800 | +0.7% | 0.24% | +7.5% |
| Q3 2021 | $375,000 | +69.7% | 14,700 | +133.3% | 0.23% | +68.1% |
| Q2 2021 | $221,000 | +370.2% | 6,300 | +447.8% | 0.14% | +365.5% |
| Q1 2021 | $47,000 | +261.5% | 1,150 | +283.3% | 0.03% | +222.2% |
| Q4 2020 | $13,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |